PubMed · 11031719
New developments in clinical immunosuppression.
Abstract
Over the last few years, the armamentarium of immunosuppressants has been enriched by a variety of new drugs, that have helped to further reduce the incidence of acute rejection episodes after kidney transplantation. Nevertheless the search for new compounds drugs continues, until tolerance, the ultimate goal of transplantation medicine can be achieved. Meanwhile we should appreciate that neither all drugs nor all patients are equal and tailor the immunosuppression to the patients' needs. To define patient groups who benefit most from different immunosuppressive protocols especially in regard to long term allograft and patient survival will warrant further prospective controlled trials.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
B Watschinger, C Wenter, D Demetriou. 2000. New developments in clinical immunosuppression.. https://pubmed.health/record/pubmed%3A11031719/new-developments-in-clinical-immunosuppression
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.